반응식
[CH:1]1([CH2:6][C:7]([NH:9][C@H:10]([C:12]([OH:14])=O)[CH3:11])=[O:8])[CH2:5][CH2:4][CH2:3][CH2:2]1.[NH2:15][CH:16]1[C:25]2[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=2)[C:19]([CH3:27])([CH3:26])[O:18][C:17]1=[O:28]>>[CH:1]1([CH2:6][C:7]([NH:9][C@H:10]([C:12]([NH:15][CH:16]2[C:25]3[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=3)[C:19]([CH3:26])([CH3:27])[O:18][C:17]2=[O:28])=[O:14])[CH3:11])=[O:8])[CH2:2][CH2:3][CH2:4][CH2:5]1참가 물질
3
실험 절차
Following General Procedure A above using N-(cyclopentylacetyl)-L-alanine and 4-amino-1,1-dimethyl-3-isochromanone, the title compound could be prepared.
출처 및 근거
- ORD 기록
- ord-b95b4b6179c04c759755b83c32101cd6
- 출처 데이터셋
- uspto-grants-2003_11
- 특허 번호
- US06653303B1
연결된 노트
불러오는 중…